Oxandrolone short stature

In expanded post-trial extension studies, diabetes mellitus developed in 12 of 3,031 patients (%) during treatment with GENOTROPIN. All 12 patients had predisposing factors, ., elevated glycated hemoglobin levels and/or marked obesity, prior to receiving GENOTROPIN. Of the 3,031 patients receiving GENOTROPIN, 61 (2%) developed symptoms of carpal tunnel syndrome , which lessened after dosage reduction or treatment interruption (52) or surgery (9). Other adverse events that have been reported include generalized edema and hypoesthesia.

Oxandrolone short stature

oxandrolone short stature

Media:

oxandrolone short statureoxandrolone short statureoxandrolone short stature